Mar 18, 2024
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
Mar 14, 2024
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
Mar 07, 2024
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
Feb 29, 2024
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast
Feb 23, 2021
Co-Diagnostics, Inc. Announces New Chief Financial Officer
Feb 16, 2021
Co-Diagnostics, Inc. to Present on Direct Saliva Testing Technology at Molecular Med Tri-Con
Jan 28, 2021
Co-Diagnostics Completes FDA EUA Submission for Extraction-Free Saliva COVID-19 Test
Jan 07, 2021
Co-Diagnostics to Present at H.C. Wainwright BioConnect 2021 Virtual Conference
Dec 14, 2020
Co-Diagnostics Announces Milestone of Over 10 Million COVID-19 Tests Sold
Nov 25, 2020
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test
Nov 17, 2020
Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests
Nov 16, 2020
Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07
Nov 02, 2020
Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share
Oct 02, 2020
Co-Diagnostics, Inc. Logix Smart Kit to be Used with Newly Authorized Saline Oral Rinse Collection
Sep 08, 2020
Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services
Sep 01, 2020
Co-Diagnostics, Inc. Issues Operational Update
Aug 25, 2020
Co-Diagnostics, Inc. To Discuss Recent Company Growth and Upcoming Expansion Plans at H.C. Wainwright Global Investment Conference
Aug 20, 2020
Co-Diagnostics, Inc. Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test
Aug 11, 2020
Co-Diagnostics, Inc. Announces Q2 2020 Earnings Release Date and Earnings Webcast
Aug 07, 2020
Co-Diagnostics, Inc. Logix Smart(TM) COVID-19 Test Authorized for Use in Australia